Skip to content

Repetitive transcranial stimulation (rTMS) in Treatment resistant obsessive compulsive disorder

Role of rTMS as an adjunctive treatment in treatment resistant OCD :A randomized double blind and sham control trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/048707
Enrollment
28
Registered
2023-01-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F422- Mixed obsessional thoughts and acts

Interventions

Intervention1: Transcranial magnetic stimulation: Coil for magnetic stimulation for 2 weeks Control Intervention1: Transcranial magnetic stimulation: Sham coil not giving magnetic stimulation for 2 we

Sponsors

Dr Kartikeya R Singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex aged between 18 to 60 years. Diagnosed cases of treatment resistant Obsessive compulsive disorder. Normotensive patients. Age range:- 18- 60 years Patients who gave written informed consent.

Exclusion criteria

Exclusion criteria: Patients unwilling to participate in the study or dropped out during study period. Current neurological or any comorbid psychiatric disorder. History of epilepsy, significant head injury, drug abuse or any neurosurgical procedure, hypertension. Subjects positive for TMS Adult Safety Screen (TASS) including individuals with cardiac pacemaker or metal in head. Subjects who received ECT (Electro Convulsive Therapy) or antipsychotics in past 6 months.

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of rTMS (Repetitive transcranial magnetic stimulation) as an adjunctive treatment modality in patients of treatment resistant OCD (Obsessive Compulsive Disorder Timepoint: Baseline and 2 weeks

Secondary

MeasureTime frame
To compare the efficacy of active low frequency rTMS as an adjunctive treatment with the sham rTMS in cases of treatment resistant OCDTimepoint: To compare the efficacy of active low frequency rTMS as an adjunctive treatment with the sham rTMS in cases of treatment resistant OCD after 2 weeks

Countries

India

Contacts

Public ContactDr Kartikeya Singh

Command Hospital, Kolkata

kramansingh@gmail.com9816683476

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026